Emergent begins dosing in phase 1 trial of intranasal therapy for cyanide poisoning
March 11 2022 - 6:15AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2024 to May 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From May 2023 to May 2024